Combination therapy is also an effective treatment; miR-124 and miR-506 jointly target DNA (cytosine-5)-methyltransferase 3B (DNMT3B) and dynamin-1 (DNM1) and reduce global DNA methylation to reduce the effect of CRC (100). The gene discussed is DNM1; the disease is colorectal carcinoma.